ARQT · Arcutis Biotherapeutics, Inc.
$28.26
+0.73 (+2.65%)
At close · Jul 21
Market Cap
$3.53B
Shares
125.08M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-16 | 2026-07-15 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-09 | 2026-06-05 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| DEF 14A | 2026-04-21 | — | |
| Investor Event Transcript | 2026-03-31 | — | |
| 10-K | 2026-02-25 | 2025-12-31 | |
| 8-K | 2026-02-25 | — | |
| 8-K | 2025-12-08 | 2025-12-03 | |
| 10-Q | 2025-10-28 | 2025-09-30 | |
| 8-K | 2025-10-28 | — | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-06-17 | 2025-06-12 | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-29 | 2025-06-12 | |
| 8-K | 2025-04-10 | — | |
| 8-K | 2025-02-25 | — | |
| 10-K | 2025-02-25 | 2024-12-31 | |
| 8-K | 2025-01-13 | 2025-01-12 | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-08-14 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 10-Q/A | 2024-07-24 | 2024-03-31 | |
| 8-K | 2024-06-18 | 2024-06-14 | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | — | |
| 8-K | 2024-04-10 | — | |
| 8-K | 2024-03-04 | 2024-02-28 | |
| 8-K | 2024-02-28 | 2024-02-27 | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-02-15 | 2024-02-12 | |
| 8-K | 2024-01-11 | — | |
| 8-K | 2023-12-18 | 2023-12-15 | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-11-03 | — | |
| 8-K | 2023-10-23 | 2023-10-19 | |
| 8-K | 2023-10-19 | — | |
| 8-K | 2023-09-27 | — | |
| 10-Q/A | 2023-09-15 | 2023-03-31 | |
| 10-Q/A | 2023-09-15 | 2023-06-30 | |
| 10-K/A | 2023-09-15 | 2022-12-31 | |
| 8-K/A | 2023-09-07 | 2023-08-15 | |
| 8-K | 2023-08-18 | 2023-08-15 | |
| 8-K | 2023-08-14 | 2023-08-10 |
Showing 1–50 of 111 filings
Key facts
CIK
1787306
CUSIP
03969K108
13F (30d)
20 filings
20 filers
Visit website
Investor relations